Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional
ArchivedFood and Drug Administration
Description
This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the Critical Path Initiative and to support regulatory science efforts. FDA and grantees will work together to develop innovative, collaborative projects in research, education, and outreach. These projects can help foster drug product innovation to 1) support efforts to accelerate drug product development; 2) support approaches to advanced manufacturing; 3) facilitate translation of basic science discoveries into therapeutics; and 4) facilitate approaches to enhance the safety, efficacy, quality, and performance of drug products. Projects are identified by FDA. Multiple awards may be funded under this NOFO and are directly dependent on drug development priorities and subject to the availability of funding.
Who can apply
- Private institutions of higher education
- Others
Contact
Terrin Brown <br/>Grantor
terrin.brown@fda.hhs.gov
- PostedJan 4, 2024
- ClosesApr 2, 2024
- Award ceiling$5,000,000
- Program funding$5,000,000
- Expected awards6
- CFDA93.103
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro